TTRX - NASDAQ

TT

Turn Therapeutics Inc.

TTRXยทNASDAQ

$6.42

+1.1%
HealthcareBiotechnology

Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$191.24M
EPS-0.2300
P/E Ratio-16.95
Earnings Date09/02/2026
TT

Turn Therapeutics Inc. Fair Value Envelope

TTRX ยท NASDAQ

Our analysis suggests that TTRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $6.42, this represents a potential HIDDEN relative to our calculated worth for Turn Therapeutics Inc..

HIDDEN
Intrinsic Value
Current Price: $6.42

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value-$2.2M
+ Cash & Equivalents$5.1M
Firm Value$2.8M
- Debt$80.4K
Equity Value$2.8M
/ Shares Outstanding28,022,826B
DCF Value$0
OVERVALUED BY 98%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
-$1.3M
-$640.7K
-$320.4K
-$160.2K
-$80.1K
-$40.0K
-$20.0K
-$10.0K
-$5.0K
-$2.5K
Maintenance CapEx
-$15.3K
-$7.6K
-$3.8K
-$1.9K
-$956
-$478
-$239
-$120
-$60
-$30
Owner Earnings
-$1.3M
-$648.4K
-$324.2K
-$162.1K
-$81.0K
-$40.5K
-$20.3K
-$10.1K
-$5.1K
-$2.5K
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
-$1.2M
-$555.9K
-$257.4K
-$119.1K
-$55.2K
-$25.5K
-$11.8K
-$5.5K
-$2.5K
-$1.2K
Terminal Value represents 0.0% of Enterprise Value
Negative Owner Earnings
This company generates negative free cash flow. Consider adjusting maintenance CapEx percentage or check the financial data.

Related Guides

Blog Categories

Continue your TTRX research with focused valuation guides.

DCF Modeling

Improve assumptions for intrinsic value accuracy.

Forecasting

Calibrate growth paths and terminal value behavior.

WACC

Refine discount-rate logic for valuation quality.

Cost of Capital

Match risk profile to expected return assumptions.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.